|
COPG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.258800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.074990E-01 |
| Normal-vs-Stage2 |
7.076400E-02 |
| Normal-vs-Stage3 |
7.173200E-01 |
| Normal-vs-Stage4 |
1.041790E-01 |
| Stage1-vs-Stage2 |
3.549800E-01 |
| Stage1-vs-Stage3 |
1.292780E-01 |
| Stage1-vs-Stage4 |
7.708200E-01 |
| Stage2-vs-Stage3 |
8.536300E-02 |
| Stage2-vs-Stage4 |
6.163400E-01 |
| Stage3-vs-Stage4 |
1.867990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.922970E-01 |
| Normal-vs-AfricanAmerican |
1.119250E-01 |
| Normal-vs-Asian |
3.367800E-01 |
| Caucasian-vs-AfricanAmerican |
4.269800E-01 |
| Caucasian-vs-Asian |
8.009600E-01 |
| AfricanAmerican-vs-Asian |
3.379800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.842590E-01 |
| Normal-vs-Female |
1.255400E-01 |
| Male-vs-Female |
9.714000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.810100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.196000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.928600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.667800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.424200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.850570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.236400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.169000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.519600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.649200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.821200E-01 |
| Classical-VS-Follicular |
2.550600E-01 |
| Classical-VS-Other |
3.403500E-02 |
| Classical-VS-Normal |
3.151900E-02 |
| Tall-VS-Follicular |
8.481600E-01 |
| Tall-VS-Other |
1.361410E-01 |
| Tall-VS-Normal |
4.115000E-01 |
| Follicular-VS-Other |
2.741000E-01 |
| Follicular-VS-Normal |
5.080200E-01 |
| Other-VS-Normal |
2.272000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.755220E-01 |
| Normal-vs-N1 |
9.601800E-01 |
| N0-vs-N1 |
2.255200E-01 |
|
|
